Kynam Capital Management, LP

Holdings History for Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (CNTA)

Symbol: CNTA on Nasdaq
Investment type: Equity / Ordinary shares, nominal value 0.002 GBP per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2024		-0.4%	$0	0	-442,704	-100%	$24.50	Q1 2024
31 Dec 2023	0.4%	-0.26%	$3,523,924	442,704	-287,768	-39%	$7.96	Q4 2023
30 Sep 2023	0.79%	+0%	$4,726,154	730,472	+1,395	+0.19%	$6.47	Q3 2023
30 Jun 2023	0.69%	0%	$4,512,987	729,077	0		$6.19	Q2 2023
31 Mar 2023	0.36%	-0%	$2,806,946	729,077	-4,849	-0.66%	$3.85	Q1 2023
31 Dec 2022	0.35%	+0%	$2,275,171	733,926	+2,405	+0.33%	$3.10	Q4 2022
30 Sep 2022	0.64%	-0.02%	$2,941,000	731,521	-26,327	-3.5%	$4.02	Q3 2022
30 Jun 2022	0.95%	+0.11%	$3,691,000	757,848	+88,748	+13%	$4.87	Q2 2022
31 Mar 2022	2%	+1.3%	$6,002,000	669,100	+430,059	+180%	$8.97	Q1 2022
31 Dec 2021	1.4%	0%	$2,692,000	239,041	0		$11.26	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.